Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
Authors:
- T. MizowakiTMT. Mizowaki
- Y. MatsuoYMY. Matsuo
- M. NakamuraMNM. Nakamura
- K. TakayamaKTK. Takayama
- Y. NorihisaYNY. Norihisa
- K. SakanakaKSK. Sakanaka
- M. HiraokaMHM. Hiraoka
Open Access
- 13 July 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 53 (5) , 777-784
Abstract
Heterogeneity correction algorithms can have a large impact on the dose distributions of stereotactic body radiation therapy (SBRT) for lung tumors. Treatment plans of 20 patients who underwent SBRT for lung tumors with the prescribed dose of 48 Gy in four fractions at the isocenter were reviewed retrospectively and recalculated with different heterogeneity correction algorithms: the pencil beam convolution algorithm with a Batho power-law correction (BPL) in Eclipse, the radiological path length algorithm (RPL), and the X-ray Voxel Monte Carlo algorithm (XVMC) in iPlan. The doses at the periphery (minimum dose and D95) of the planning target volume (PTV) were compared using the same monitor units among the three heterogeneity correction algorithms, and the monitor units were compared between two methods of dose prescription, that is, an isocenter dose prescription (IC prescription) and dose-volume based prescription (D95 prescription). Mean values of the dose at the periphery of the PTV were significantly lower with XVMC than with BPL using the same monitor units (P < 0.001). In addition, under IC prescription using BPL, RPL and XVMC, the ratios of mean values of monitor units were 1, 0.959 and 0.986, respectively. Under D95 prescription, they were 1, 0.937 and 1.088, respectively. These observations indicated that the application of XVMC under D95 prescription results in an increase in the actually delivered dose by 8.8% on average compared with the application of BPL. The appropriateness of switching heterogeneity correction algorithms and dose prescription methods should be carefully validated from a clinical viewpoint.Keywords
This publication has 26 references indexed in Scilit:
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on doseRadiation Oncology, 2008
- SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systemsPhysics in Medicine & Biology, 2007
- Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC)Cancer, 2007
- Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situationsPhysics in Medicine & Biology, 2006
- Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403)Physics in Medicine & Biology, 2006
- Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motionsActa Oncologica, 2006
- Monte Carlo- versus pencil-beam-/collapsed-cone-dose calculation in a heterogeneous multi-layer phantomPhysics in Medicine & Biology, 2005